ROCKVILLE, MD and SHENZHEN, CHINA, Jan 5, 2023 – (ACN Newswire via SEAPRWire.com) – HighTide Therapeutics Inc. (“HighTide”), a globally integrated clinical-stage biopharmaceutical company developing […]
London, UK, December 30, 2022 – (SEAPRWire) – UK Intis Telecom LTD announces the launch of the new top-level domain name zone (TLD) – it.com. This new […]
HIROSHIMA, Japan, Nov 22, 2022 – (JCN Newswire via SEAPRWire.com) – Mazda Motor Corporation today announces an update to its Mid-Term Management Plan and basic […]
JAKARTA, Oct 12, 2022 – (ACN Newswire via SEAPRWire.com) – The Ministry of Agrarian and Spatial Planning/National Land Agency (ATR/BPN) is offering building use rights […]
SYDNEY, AU, Sep 6, 2022 – (ACN Newswire via SEAPRWire.com) – Avance Clinical, the Australian CRO for biotechs, has expanded into North America with the […]
HONG KONG, Aug 24, 2022 – (ACN Newswire via SEAPRWire.com) – Zhaoke Ophthalmology Limited (“Zhaoke Ophthalmology” or the “Company”, SEHK: 6622), a leading ophthalmic pharmaceutical […]
Play-to-earn disruptor to finalize private sale token distribution ahead of schedule Mahe, Seychelles, June 25, 2022 – (SEAPRWire) -Nakamoto Games ($NAKA), the token powering the industry’s fastest-growing play-to-earn […]
HONG KONG, Jun 15, 2022 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”, stock […]
HONG KONG, Mar 22, 2022 – (ACN Newswire via SEAPRWire.com) – Essex Bio-Technology Ltd (“Essex” or the “Group”, Stock Code: 1061.HK) today announced the annual […]
HONG KONG, Feb 7, 2022 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”, stock […]
ADELAIDE, AUS, Jan 18, 2022 – (ACN Newswire via SEAPRWire.com) – Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has […]
HANGZHOU, CHINA, Jan 12, 2022 – (ACN Newswire via SEAPRWire.com) – On January 8, AIM Vaccine held a meeting at Shulan (Hangzhou) Hospital to report […]
TOKYO, Dec 24, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that lecanemab, an investigational anti-amyloid beta (Abeta) […]
HONG KONG, Nov 30, 2021 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab”, or the “Company”, stock code: 3681.HK), a Hong Kong-based biopharmaceutical […]
TOKYO, Nov 11, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today results of new clinical, biomarker and safety […]
TOKYO, Nov 9, 2021 – (JCN Newswire via SEAPRWire.com) – Mitsubishi Corporation (MC) and The Kinki Sharyo Co., Ltd. (Kinki Sharyo) are pleased to announce […]
HONG KONG, Sep 17, 2021 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (HKEX 3681.HK, “SinoMab”) announced with Suzhou Sinovent Pharmaceuticals Co., Ltd. (“Sinovent”) […]
MADRID, Sep 7, 2021 – (ACN Newswire via SEAPRWire.com) – Bit2Me has closed the first phase of its ICO (Initial Coin Offering) in just 59 […]
SUZHOU, CHINA, Aug 30, 2021 – (ACN Newswire via SEAPRWire.com) – Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small […]